BIOMERICA INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $4.70 per share for the 9-month period ending 2026-02-28, per its 10-Q filed 2026-04-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-04-13
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2025-08-31 was $12.70, a 525.62% increase year-over-year.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-08-31 was $2.03, a 38.67% decline year-over-year.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-08-31 was $3.31.
- BIOMERICA INC share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2018-08-31 was $0.99, a 4.81% decline year-over-year.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month |
|---|---|---|---|
| 2026-02-28 | $4.70 10-Q · filed 2026-04-13 | ||
| 2025-11-30 | $17.38 10-Q · filed 2026-01-14 | ||
| 2025-08-31 | $12.70 10-Q · filed 2025-10-14 | ||
| 2025-02-28 | $1.68 10-Q · filed 2025-04-14 | ||
| 2024-11-30 | $2.15 10-Q · filed 2025-01-14 | ||
| 2024-08-31 | $2.03 10-Q · filed 2024-10-15 | ||
| 2024-02-29 | $4.97 10-Q · filed 2024-04-12 | ||
| 2023-11-30 | $4.90 10-Q · filed 2024-01-16 | ||
| 2023-08-31 | $3.31 10-Q · filed 2023-10-12 | ||
| 2018-08-31 | $0.99 10-Q · filed 2018-10-15 | ||
| 2017-08-31 | $1.04 10-Q · filed 2017-10-16 | ||
| 2016-08-31 | $0.96 10-Q · filed 2016-10-17 | ||
| 2015-08-31 | $0.69 10-Q · filed 2015-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |